These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

73 related articles for article (PubMed ID: 11362383)

  • 1. SPV-30 may offer CD4 increase.
    Posit Aware; 1995; ():7. PubMed ID: 11362383
    [TBL] [Abstract][Full Text] [Related]  

  • 2. SPV-30: where's the proof?
    Grodeck B
    Posit Aware; 1995; ():7. PubMed ID: 11362577
    [TBL] [Abstract][Full Text] [Related]  

  • 3. No claims of SPV-30 success.
    Stokes D
    Posit Aware; 1995; ():4. PubMed ID: 11362664
    [TBL] [Abstract][Full Text] [Related]  

  • 4. PCM-4, OTC hopeful?
    Servilio J
    Posit Aware; 1995; ():7. PubMed ID: 11362672
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Happiness reigns in the drug marketplace.
    Kuller K
    GMHC Treat Issues; 1997; 11(4/5):6-8. PubMed ID: 11364376
    [TBL] [Abstract][Full Text] [Related]  

  • 6. PIT study produces more questions than answers.
    TreatmentUpdate; 1998 Jul; 10(5):1-2. PubMed ID: 11365623
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Boxwood.
    Treat Rev; 1995; (no 17):7. PubMed ID: 11362302
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A multicentre study to determine the efficacy and tolerability of a combination of nelfinavir (VIRACEPT), zalcitabine (HIVID) and zidovudine in the treatment of HIV infected Nigerian patients.
    Idoko JA; Akinsete L; Abalaka AD; Keshinro LB; Dutse L; Onyenekwe B; Lhekwaba A; Njoku OS; Kehinde MO; Wambebe CO
    West Afr J Med; 2002; 21(2):83-6. PubMed ID: 12403023
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Protease inhibitors and beyond: interview with David Feigal, M.D. Interview by John S James.
    Feigal D
    AIDS Treat News; 1995 Mar; (no 219):1-6. PubMed ID: 11362331
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Phase II placebo-controlled study of V-1 Immunitor as a therapeutic modality for treatment of HIV.
    Bourinbaiar AS; Jirathitikal V; Metadilogkul O; Sooksathan P; Paiboon P; Aemsri S; Prapai P; Chaodon K
    J Clin Virol; 2004 Dec; 31 Suppl 1():S55-62. PubMed ID: 15567095
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Granulocyte-macrophage colony-stimulating factor induces modest increases in plasma human immunodeficiency virus (HIV) type 1 RNA levels and CD4+ lymphocyte counts in patients with uncontrolled HIV infection.
    Jacobson JM; Lederman MM; Spritzler J; Valdez H; Tebas P; Skowron G; Wang R; Jackson JB; Fox L; Landay A; Gilbert MJ; O'Neil D; Bancroft L; Al-Harthi L; Jacobson MA; Merigan TC; Glesby MJ;
    J Infect Dis; 2003 Dec; 188(12):1804-14. PubMed ID: 14673758
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lessons learned from independent central review.
    Ford R; Schwartz L; Dancey J; Dodd LE; Eisenhauer EA; Gwyther S; Rubinstein L; Sargent D; Shankar L; Therasse P; Verweij J
    Eur J Cancer; 2009 Jan; 45(2):268-74. PubMed ID: 19101138
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Recommendations from the GESIDA/Spanish AIDS Plan regarding antiretroviral treatment in adults with human immunodeficiency virus infection (update February 2009)].
    Panel de expertos de Gesida y Plan Nacional sobre el Sida
    Enferm Infecc Microbiol Clin; 2009 Apr; 27(4):222-35. PubMed ID: 19246124
    [TBL] [Abstract][Full Text] [Related]  

  • 14. SPV-30 shows encouraging results.
    AIDS Patient Care STDS; 1996 Jun; 10(3):186-7. PubMed ID: 11361631
    [No Abstract]   [Full Text] [Related]  

  • 15. Effect of diethylcarbamazine on HIV load, CD4%, and CD4/CD8 ratio in HIV-infected adult Tanzanians with or without lymphatic filariasis: randomized double-blind and placebo-controlled cross-over trial.
    Nielsen NO; Simonsen PE; Dalgaard P; Krarup H; Magnussen P; Magesa S; Friis H
    Am J Trop Med Hyg; 2007 Sep; 77(3):507-13. PubMed ID: 17827369
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Indinavir--study highlights importance of CD4+ counts over viral load.
    TreatmentUpdate; 1998 Nov; 10(9):2-3. PubMed ID: 11365923
    [TBL] [Abstract][Full Text] [Related]  

  • 17. IL-2: controlled trial finds major CD4 increases.
    James JS
    AIDS Treat News; 1996 Nov; (No 258):3-4. PubMed ID: 11363996
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inverse correlation between CD8+ lymphocyte apoptosis and CD4+ cell counts during potent antiretroviral therapy in HIV patients.
    Grelli S; d'Ettorre G; Lauria F; Montella F; Di Traglia L; Lichtner M; Vullo V; Favalli C; Vella S; Macchi B; Mastino A
    J Antimicrob Chemother; 2004 Mar; 53(3):494-500. PubMed ID: 14963063
    [TBL] [Abstract][Full Text] [Related]  

  • 19. New vaccine+HAART treatment trial enrolling at NIH. National Institutes of Health.
    James JS
    AIDS Treat News; 1998 Aug; (No 300):3-4. PubMed ID: 11365687
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Gender difference in viral load.
    Proj Inf Perspect; 1999 Apr; (27):18-9. PubMed ID: 11366734
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.